Cravath Publishes Summer 2026 Issue of Alumni Journal
Annmarie M. Terraciano advises on environmental matters relating to mergers and acquisitions, capital markets transactions, financings and other business transactions, as well as on environmental‑related proceedings and indemnification disputes.
Ms. Terraciano also counsels companies on matters relating to Environmental, Social and Governance (“ESG”) concerns, including shareholder engagement, sustainability reporting and disclosure and diligence and integration matters.
Ms. Terraciano has worked on hundreds of transactions across all industries in the U.S. and internationally, including deals in heavy manufacturing; chemical production and refining; pulp and paper; iron and steel; mining; oil and gas exploration, refining, transport and services; power generation; pharmaceuticals; electronics; telecommunications; food and beverage production; consumer goods; insurance; commercial real estate and retail chains. She also provides counseling on environmental compliance matters; environmental proceedings; environmental indemnification disputes; and environmental aspects of periodic reporting obligations under securities laws.
Ms. Terraciano has been recognized for her transactional and regulatory work in the environmental area by, among others, Chambers USA, The Legal 500 US, The Best Lawyers in America and Super Lawyers.
Ms. Terraciano was born in New York. She received a B.A. cum laude from Wellesley College, in 1989, an M.S. from the University of Wisconsin – Madison in 1994 and a J.D. from Columbia Law School in 1998, where she was a Harlan Fiske Stone Scholar and an Articles Editor of the Human Rights Law Review.
Ms. Terraciano joined Cravath in 2001 and was named a senior attorney in 2012 and of counsel in 2025. Prior to joining Cravath, she practiced environmental litigation at a law firm in New York.
Ms. Terraciano also counsels companies on matters relating to Environmental, Social and Governance (“ESG”) concerns, including shareholder engagement, sustainability reporting and disclosure and diligence and integration matters.
Ms. Terraciano has worked on hundreds of transactions across all industries in the U.S. and internationally, including deals in heavy manufacturing; chemical production and refining; pulp and paper; iron and steel; mining; oil and gas exploration, refining, transport and services; power generation; pharmaceuticals; electronics; telecommunications; food and beverage production; consumer goods; insurance; commercial real estate and retail chains. She also provides counseling on environmental compliance matters; environmental proceedings; environmental indemnification disputes; and environmental aspects of periodic reporting obligations under securities laws.
Ms. Terraciano has been recognized for her transactional and regulatory work in the environmental area by, among others, Chambers USA, The Legal 500 US, The Best Lawyers in America and Super Lawyers.
Ms. Terraciano was born in New York. She received a B.A. cum laude from Wellesley College, in 1989, an M.S. from the University of Wisconsin – Madison in 1994 and a J.D. from Columbia Law School in 1998, where she was a Harlan Fiske Stone Scholar and an Articles Editor of the Human Rights Law Review.
Ms. Terraciano joined Cravath in 2001 and was named a senior attorney in 2012 and of counsel in 2025. Prior to joining Cravath, she practiced environmental litigation at a law firm in New York.
Education
-
J.D., 1998, Columbia Law SchoolHarlan Fiske Stone Scholar
-
M.S., 1994, University of Wisconsin - Madison
-
B.A., 1989, Wellesley Collegecum laude
Admitted In
- New York
Professional Affiliations
American Bar Association
New York City Bar Association
- Member of the Committee on International Environmental Law
Rankings
Best Lawyers in America
- Environmental Law (2027‑2010)
Chambers USA
- Environment: Mainly Transactional - New York (2026‑2012)
The Legal 500 US
- Environment: Transactional (2026-2017, 2015, 2014, 2013, 2011)
Super Lawyers - New York
- Environmental (2024‑2012)
Deals & Cases
October 29, 2026
ADT’s $15.3 Billion Acquisition by Thrive Holdings
On October 29, 2026, ADT Inc. (“ADT”), a leading provider of security, interactive and smart home solutions serving residential and small business customers in the U.S., and Thrive Holdings, a permanent capital holding company focused on investing in established businesses and advancing their capabilities through technology, announced a definitive agreement under which Thrive Holdings will acquire ADT in an all‑cash transaction. The agreement values ADT at approximately $7.6 billion in equity value and $15.3 billion in enterprise value. Under the terms of the agreement, which ADT’s Board of Directors unanimously approved, ADT stockholders will receive $10.00 per share in cash upon completion. Following completion, ADT will become privately held and its common stock will cease trading on the New York Stock Exchange. Cravath is representing ADT in connection with the transaction.
Deals & Cases
October 29, 2026
Instacart’s $17 Billion Acquisition by DoorDash
On October 29, 2026, DoorDash, Inc. (“DoorDash”) and Maplebear Inc. (d.b.a. Instacart) (“Instacart”) announced a definitive agreement under which DoorDash will acquire Instacart for a total value of $65.00 for each Instacart share, or an equity value of approximately $17 billion. The aggregate transaction consideration will be at least 75% cash, with Instacart stockholders able to elect cash, DoorDash stock, or a combination of both, subject to proration so that DoorDash stock does not exceed 25% of the aggregate consideration. Instacart's board of directors has unanimously approved the agreement. Cravath is representing Instacart in connection with the transaction.
Deals & Cases
October 20, 2026
Neurotech’s Acquisition by Alcon
On October 20, 2026, Alcon, a global leader in eye care, announced it has acquired Neurotech Pharmaceuticals, Inc. (“Neurotech”), a company focused on developing innovative cell therapies for chronic and neurodegenerative eye diseases, for $550 million. Alcon may be required to make additional contingent payments, including upon the achievement of commercial milestones. This acquisition expands Alcon's retina portfolio with ENCELTO™, the first and only U.S. FDA-approved treatment for adults with idiopathic Macular Telangiectasia Type 2 (“MacTel”), a rare, progressive retinal disease that leads to irreversible central vision loss that has historically had no approved treatment options. Cravath represented Neurotech in connection with the transaction.
Deals & Cases
October 07, 2026
Alumina Pty Ltd and Alcoa Nederland Holding B.V.’s $2.6 Billion High‑Yield Senior Notes Offering
Cravath represented the initial purchasers in connection with the $2.6 billion 144A/Reg S. high‑yield senior notes offering of Alumina Pty Ltd and Alcoa Nederland Holding B.V., wholly owned subsidiaries of Alcoa Corporation, a global industry leader in the production of bauxite, alumina and aluminum products. Proceeds of the offering will be used to finance Alcoa Corporation's acquisition of the interests of South32 Limited in bauxite mine, alumina refinery and certain aluminum smelter operations. The transaction closed on September 23, 2026.
Deals & Cases
October 01, 2026
Corteva’s Spin‑Off of Seed and Genetics Business
On October 1, 2026, Corteva, Inc. (“Corteva”) announced it has successfully spun off its advanced seed and genetics business as a new public company, Vylor, Inc., and will move forward as a leading, pure‑play global crop protection company. Cravath is representing Corteva in connection with the transaction.
Firm News
November 20, 2025
Cravath Announces New Partners and Of Counsels
Cravath has elected the following new partners, who will become members of the Firm on January 1, 2026:
Annmarie M. Terraciano advises on environmental matters relating to mergers and acquisitions, capital markets transactions, financings and other business transactions, as well as on environmental‑related proceedings and indemnification disputes.
Ms. Terraciano also counsels companies on matters relating to Environmental, Social and Governance (“ESG”) concerns, including shareholder engagement, sustainability reporting and disclosure and diligence and integration matters.
Ms. Terraciano has worked on hundreds of transactions across all industries in the U.S. and internationally, including deals in heavy manufacturing; chemical production and refining; pulp and paper; iron and steel; mining; oil and gas exploration, refining, transport and services; power generation; pharmaceuticals; electronics; telecommunications; food and beverage production; consumer goods; insurance; commercial real estate and retail chains. She also provides counseling on environmental compliance matters; environmental proceedings; environmental indemnification disputes; and environmental aspects of periodic reporting obligations under securities laws.
Ms. Terraciano has been recognized for her transactional and regulatory work in the environmental area by, among others, Chambers USA, The Legal 500 US, The Best Lawyers in America and Super Lawyers.
Ms. Terraciano was born in New York. She received a B.A. cum laude from Wellesley College, in 1989, an M.S. from the University of Wisconsin – Madison in 1994 and a J.D. from Columbia Law School in 1998, where she was a Harlan Fiske Stone Scholar and an Articles Editor of the Human Rights Law Review.
Ms. Terraciano joined Cravath in 2001 and was named a senior attorney in 2012 and of counsel in 2025. Prior to joining Cravath, she practiced environmental litigation at a law firm in New York.
Ms. Terraciano also counsels companies on matters relating to Environmental, Social and Governance (“ESG”) concerns, including shareholder engagement, sustainability reporting and disclosure and diligence and integration matters.
Ms. Terraciano has worked on hundreds of transactions across all industries in the U.S. and internationally, including deals in heavy manufacturing; chemical production and refining; pulp and paper; iron and steel; mining; oil and gas exploration, refining, transport and services; power generation; pharmaceuticals; electronics; telecommunications; food and beverage production; consumer goods; insurance; commercial real estate and retail chains. She also provides counseling on environmental compliance matters; environmental proceedings; environmental indemnification disputes; and environmental aspects of periodic reporting obligations under securities laws.
Ms. Terraciano has been recognized for her transactional and regulatory work in the environmental area by, among others, Chambers USA, The Legal 500 US, The Best Lawyers in America and Super Lawyers.
Ms. Terraciano was born in New York. She received a B.A. cum laude from Wellesley College, in 1989, an M.S. from the University of Wisconsin – Madison in 1994 and a J.D. from Columbia Law School in 1998, where she was a Harlan Fiske Stone Scholar and an Articles Editor of the Human Rights Law Review.
Ms. Terraciano joined Cravath in 2001 and was named a senior attorney in 2012 and of counsel in 2025. Prior to joining Cravath, she practiced environmental litigation at a law firm in New York.
Education
-
J.D., 1998, Columbia Law SchoolHarlan Fiske Stone Scholar
-
M.S., 1994, University of Wisconsin - Madison
-
B.A., 1989, Wellesley Collegecum laude
Admitted In
- New York
Professional Affiliations
American Bar Association
New York City Bar Association
- Member of the Committee on International Environmental Law
Rankings
Best Lawyers in America
- Environmental Law (2027‑2010)
Chambers USA
- Environment: Mainly Transactional - New York (2026‑2012)
The Legal 500 US
- Environment: Transactional (2026-2017, 2015, 2014, 2013, 2011)
Super Lawyers - New York
- Environmental (2024‑2012)
Deals & Cases
October 29, 2026
ADT’s $15.3 Billion Acquisition by Thrive Holdings
On October 29, 2026, ADT Inc. (“ADT”), a leading provider of security, interactive and smart home solutions serving residential and small business customers in the U.S., and Thrive Holdings, a permanent capital holding company focused on investing in established businesses and advancing their capabilities through technology, announced a definitive agreement under which Thrive Holdings will acquire ADT in an all‑cash transaction. The agreement values ADT at approximately $7.6 billion in equity value and $15.3 billion in enterprise value. Under the terms of the agreement, which ADT’s Board of Directors unanimously approved, ADT stockholders will receive $10.00 per share in cash upon completion. Following completion, ADT will become privately held and its common stock will cease trading on the New York Stock Exchange. Cravath is representing ADT in connection with the transaction.
Deals & Cases
October 29, 2026
Instacart’s $17 Billion Acquisition by DoorDash
On October 29, 2026, DoorDash, Inc. (“DoorDash”) and Maplebear Inc. (d.b.a. Instacart) (“Instacart”) announced a definitive agreement under which DoorDash will acquire Instacart for a total value of $65.00 for each Instacart share, or an equity value of approximately $17 billion. The aggregate transaction consideration will be at least 75% cash, with Instacart stockholders able to elect cash, DoorDash stock, or a combination of both, subject to proration so that DoorDash stock does not exceed 25% of the aggregate consideration. Instacart's board of directors has unanimously approved the agreement. Cravath is representing Instacart in connection with the transaction.
Deals & Cases
October 20, 2026
Neurotech’s Acquisition by Alcon
On October 20, 2026, Alcon, a global leader in eye care, announced it has acquired Neurotech Pharmaceuticals, Inc. (“Neurotech”), a company focused on developing innovative cell therapies for chronic and neurodegenerative eye diseases, for $550 million. Alcon may be required to make additional contingent payments, including upon the achievement of commercial milestones. This acquisition expands Alcon's retina portfolio with ENCELTO™, the first and only U.S. FDA-approved treatment for adults with idiopathic Macular Telangiectasia Type 2 (“MacTel”), a rare, progressive retinal disease that leads to irreversible central vision loss that has historically had no approved treatment options. Cravath represented Neurotech in connection with the transaction.
Deals & Cases
October 07, 2026
Alumina Pty Ltd and Alcoa Nederland Holding B.V.’s $2.6 Billion High‑Yield Senior Notes Offering
Cravath represented the initial purchasers in connection with the $2.6 billion 144A/Reg S. high‑yield senior notes offering of Alumina Pty Ltd and Alcoa Nederland Holding B.V., wholly owned subsidiaries of Alcoa Corporation, a global industry leader in the production of bauxite, alumina and aluminum products. Proceeds of the offering will be used to finance Alcoa Corporation's acquisition of the interests of South32 Limited in bauxite mine, alumina refinery and certain aluminum smelter operations. The transaction closed on September 23, 2026.
Deals & Cases
October 01, 2026
Corteva’s Spin‑Off of Seed and Genetics Business
On October 1, 2026, Corteva, Inc. (“Corteva”) announced it has successfully spun off its advanced seed and genetics business as a new public company, Vylor, Inc., and will move forward as a leading, pure‑play global crop protection company. Cravath is representing Corteva in connection with the transaction.
Firm News
November 20, 2025
Cravath Announces New Partners and Of Counsels
Cravath has elected the following new partners, who will become members of the Firm on January 1, 2026:
Cravath Bicentennial
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.